agilon health inc - AGL

AGL

Close Chg Chg %
19.80 -0.76 -3.84%

Closed Market

19.04

-0.76 (3.84%)

Volume: 338.91K

Last Updated:

Apr 10, 2026, 3:59 PM EDT

Company Overview: agilon health inc - AGL

AGL Key Data

Open

$19.71

Day Range

18.45 - 20.77

52 Week Range

7.48 - 144.25

Market Cap

$329.46M

Shares Outstanding

16.61M

Public Float

N/A

Beta

0.33

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$24.46

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

274.30K

 

AGL Performance

1 Week
 
77.09%
 
1 Month
 
26.80%
 
3 Months
 
-23.31%
 
1 Year
 
-86.61%
 
5 Years
 
N/A
 

AGL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 17
Full Ratings ➔

About agilon health inc - AGL

Agilon Health, Inc. engages in the provision of healthcare services. It also provides capital, data, payor relationships, executive experience, and contract support that allow physician groups to take on the risk of total care for their patients. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Westerville, OH.

AGL At a Glance

Agilon Health, Inc.
440 Polaris Parkway
Westerville, Ohio 43082
Phone 1-562-256-3800 Revenue 5.93B
Industry Medical/Nursing Services Net Income -405,347,000.00
Sector Health Services Employees 856
Fiscal Year-end 12 / 2026
View SEC Filings

AGL Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.048
Price to Book Ratio 2.254
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.094
Enterprise Value to Sales 0.006
Total Debt to Enterprise Value 1.001

AGL Efficiency

Revenue/Employee 6,930,579.439
Income Per Employee -473,536.215
Receivables Turnover 8.805
Total Asset Turnover 3.948

AGL Liquidity

Current Ratio 1.019
Quick Ratio 1.019
Cash Ratio 0.265

AGL Profitability

Gross Margin -3.179
Operating Margin -7.098
Pretax Margin -6.811
Net Margin -6.833
Return on Assets -26.976
Return on Equity -135.639
Return on Total Capital -247.844
Return on Invested Capital -123.437

AGL Capital Structure

Total Debt to Total Equity 29.049
Total Debt to Total Capital 22.51
Total Debt to Total Assets 2.896
Long-Term Debt to Equity 13.869
Long-Term Debt to Total Capital 10.747
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Agilon Health Inc - AGL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.71B 4.32B 6.06B 5.93B
Sales Growth
+47.70% +59.38% +40.41% -2.11%
Cost of Goods Sold (COGS) incl D&A
2.61B 4.26B 6.08B 6.12B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
13.77M 20.16M 24.46M 28.59M
Depreciation
4.07M 12.16M 12.20M 15.19M
Amortization of Intangibles
9.70M 8.00M 12.26M 13.40M
COGS Growth
+47.30% +63.34% +42.63% +0.67%
Gross Income
98.51M 53.63M (19.62M) (188.62M)
Gross Income Growth
+59.23% -45.56% -136.59% -861.24%
Gross Profit Margin
+3.64% +1.24% -0.32% -3.18%
2022 2023 2024 2025 5-year trend
SG&A Expense
216.47M 285.57M 264.33M 232.46M
Research & Development
- - - -
-
Other SG&A
216.47M 285.57M 264.33M 232.46M
SGA Growth
-51.13% +31.92% -7.44% -12.06%
Other Operating Expense
- - - -
-
Unusual Expense
7.93M 188.00K 8.17M 42.16M
EBIT after Unusual Expense
(125.89M) (232.13M) (292.13M) (463.24M)
Non Operating Income/Expense
24.73M 44.33M 49.48M 65.78M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- 16.49M 14.99M (1.83M)
Interest Expense
4.53M 6.66M 6.18M 6.64M
Interest Expense Growth
-26.37% +47.14% -7.22% +7.51%
Gross Interest Expense
4.53M 6.66M 6.18M 6.64M
Interest Capitalized
- - - -
-
Pretax Income
(105.69M) (194.46M) (248.83M) (404.10M)
Pretax Income Growth
+73.88% -83.99% -27.96% -62.40%
Pretax Margin
-3.90% -4.51% -4.11% -6.81%
Income Tax
1.64M 791.00K 1.45M 1.25M
Income Tax - Current - Domestic
1.11M 1.50M (18.00K) 766.00K
Income Tax - Current - Foreign
- 893.00K 1.25M 725.00K
Income Tax - Deferred - Domestic
530.00K (1.47M) 357.00K 144.00K
Income Tax - Deferred - Foreign
- (134.00K) (142.00K) (384.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- 16.49M 14.99M (1.83M)
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(107.33M) (195.25M) (250.28M) (405.35M)
Minority Interest Expense
- (311.00K) (207.00K) 50.00K
Net Income
(107.02M) (195.05M) (250.33M) (405.35M)
Net Income Growth
+73.59% -82.26% -28.34% -61.93%
Net Margin Growth
-3.95% -4.52% -4.13% -6.83%
Extraordinaries & Discontinued Operations
- 465.00K (20.00M) (1.06M)
Discontinued Operations
- 465.00K (20.00M) (1.06M)
Net Income After Extraordinaries
(106.55M) (215.05M) (251.39M) (405.35M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(106.55M) (215.05M) (251.39M) (405.35M)
EPS (Basic)
-6.5265 -13.1475 -15.2925 -24.4792
EPS (Basic) Growth
+74.33% -101.45% -16.31% -60.07%
Basic Shares Outstanding
16.33M 16.36M 16.44M 16.56M
EPS (Diluted)
-6.5265 -13.1475 -15.2925 -24.4792
EPS (Diluted) Growth
+74.33% -101.45% -16.31% -60.07%
Diluted Shares Outstanding
16.33M 16.36M 16.44M 16.56M
EBITDA
(104.19M) (211.78M) (259.49M) (392.48M)
EBITDA Growth
+71.57% -103.27% -22.53% -51.25%
EBITDA Margin
-3.85% -4.91% -4.28% -6.62%

Snapshot

Average Recommendation HOLD Average Target Price 19.92
Number of Ratings 17 Current Quarters Estimate -1.261
FY Report Date 06 / 2026 Current Year's Estimate -5.718
Last Quarter’s Earnings 0.985 Median PE on CY Estimate N/A
Year Ago Earnings -24.50 Next Fiscal Year Estimate -4.269
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 17 17 17 15
Mean Estimate -1.26 -1.74 -5.72 -4.27
High Estimates -0.25 -0.25 -1.75 -0.05
Low Estimate -5.25 -5.00 -10.43 -7.36
Coefficient of Variance -100.95 -63.30 -34.98 -46.77

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 13 13 13
UNDERWEIGHT 1 1 1
SELL 1 1 1
MEAN Hold Hold Hold

Agilon Health Inc in the News